Cosmo Pharmaceuticals N.V.
Get $10 bonus on your first $100 deposit for CMOPF
Get $10 bonus on your first $100 deposit for CMOPF
Cosmo Pharmaceuticals N.V. (CMOPF) Stock Competitors & Peer Comparison
See (CMOPF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CMOPF | $109.00 | +6.19% | 1.8B | -419.23 | -$0.26 | +2.20% |
| BMYMP | $400.00 | -57.46% | 814.6B | 1777.78 | $0.23 | +4.19% |
| RHHBF | $416.25 | +6.34% | 331.3B | 20.71 | $20.10 | +2.25% |
| RHHBY | $49.85 | -1.09% | 321.1B | 19.86 | $2.51 | +2.01% |
| RHHVF | $403.29 | +8.69% | 321B | 19.93 | $20.24 | +3.09% |
| NVSEF | $154.88 | +6.45% | 295.5B | 21.69 | $7.14 | +1.99% |
| AZNCF | $189.90 | -1.35% | 294.4B | 31.49 | $6.03 | +1.68% |
| SNYNF | $95.27 | +1.00% | 114.6B | 20.40 | $4.67 | +4.63% |
| GLAXF | $26.75 | -1.83% | 107B | 14.54 | $1.84 | +3.30% |
| CHGCY | $28.90 | -1.26% | 95.1B | 34.82 | $0.83 | +2.84% |
Stock Comparison
CMOPF vs BMYMP Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, BMYMP has a market cap of 814.6B. Regarding current trading prices, CMOPF is priced at $109.00, while BMYMP trades at $400.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas BMYMP's P/E ratio is 1777.78. In terms of profitability, CMOPF's ROE is -0.01%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, CMOPF is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for CMOPF.Check BMYMP's competition here
CMOPF vs RHHBF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, RHHBF has a market cap of 331.3B. Regarding current trading prices, CMOPF is priced at $109.00, while RHHBF trades at $416.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas RHHBF's P/E ratio is 20.71. In terms of profitability, CMOPF's ROE is -0.01%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, CMOPF is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check RHHBF's competition here
CMOPF vs RHHBY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, RHHBY has a market cap of 321.1B. Regarding current trading prices, CMOPF is priced at $109.00, while RHHBY trades at $49.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas RHHBY's P/E ratio is 19.86. In terms of profitability, CMOPF's ROE is -0.01%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, CMOPF is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check RHHBY's competition here
CMOPF vs RHHVF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, RHHVF has a market cap of 321B. Regarding current trading prices, CMOPF is priced at $109.00, while RHHVF trades at $403.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas RHHVF's P/E ratio is 19.93. In terms of profitability, CMOPF's ROE is -0.01%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, CMOPF is more volatile compared to RHHVF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check RHHVF's competition here
CMOPF vs NVSEF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, NVSEF has a market cap of 295.5B. Regarding current trading prices, CMOPF is priced at $109.00, while NVSEF trades at $154.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas NVSEF's P/E ratio is 21.69. In terms of profitability, CMOPF's ROE is -0.01%, compared to NVSEF's ROE of +0.33%. Regarding short-term risk, CMOPF is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check NVSEF's competition here
CMOPF vs AZNCF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, AZNCF has a market cap of 294.4B. Regarding current trading prices, CMOPF is priced at $109.00, while AZNCF trades at $189.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas AZNCF's P/E ratio is 31.49. In terms of profitability, CMOPF's ROE is -0.01%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, CMOPF is more volatile compared to AZNCF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check AZNCF's competition here
CMOPF vs SNYNF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, SNYNF has a market cap of 114.6B. Regarding current trading prices, CMOPF is priced at $109.00, while SNYNF trades at $95.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas SNYNF's P/E ratio is 20.40. In terms of profitability, CMOPF's ROE is -0.01%, compared to SNYNF's ROE of +0.15%. Regarding short-term risk, CMOPF is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check SNYNF's competition here
CMOPF vs GLAXF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, GLAXF has a market cap of 107B. Regarding current trading prices, CMOPF is priced at $109.00, while GLAXF trades at $26.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas GLAXF's P/E ratio is 14.54. In terms of profitability, CMOPF's ROE is -0.01%, compared to GLAXF's ROE of +0.37%. Regarding short-term risk, CMOPF is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check GLAXF's competition here
CMOPF vs CHGCY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, CHGCY has a market cap of 95.1B. Regarding current trading prices, CMOPF is priced at $109.00, while CHGCY trades at $28.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas CHGCY's P/E ratio is 34.82. In terms of profitability, CMOPF's ROE is -0.01%, compared to CHGCY's ROE of +0.23%. Regarding short-term risk, CMOPF is more volatile compared to CHGCY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check CHGCY's competition here
CMOPF vs CHGCF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, CHGCF has a market cap of 91.5B. Regarding current trading prices, CMOPF is priced at $109.00, while CHGCF trades at $55.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas CHGCF's P/E ratio is 33.49. In terms of profitability, CMOPF's ROE is -0.01%, compared to CHGCF's ROE of +0.22%. Regarding short-term risk, CMOPF is less volatile compared to CHGCF. This indicates potentially lower risk in terms of short-term price fluctuations for CMOPF.Check CHGCF's competition here
CMOPF vs BAYRY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, BAYRY has a market cap of 44.2B. Regarding current trading prices, CMOPF is priced at $109.00, while BAYRY trades at $11.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas BAYRY's P/E ratio is -10.62. In terms of profitability, CMOPF's ROE is -0.01%, compared to BAYRY's ROE of -0.12%. Regarding short-term risk, CMOPF is more volatile compared to BAYRY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check BAYRY's competition here
CMOPF vs OTSKY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, OTSKY has a market cap of 38.6B. Regarding current trading prices, CMOPF is priced at $109.00, while OTSKY trades at $35.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas OTSKY's P/E ratio is 16.57. In terms of profitability, CMOPF's ROE is -0.01%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, CMOPF is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check OTSKY's competition here
CMOPF vs OTSKF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, OTSKF has a market cap of 38.1B. Regarding current trading prices, CMOPF is priced at $109.00, while OTSKF trades at $72.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas OTSKF's P/E ratio is 14.92. In terms of profitability, CMOPF's ROE is -0.01%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, CMOPF is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check OTSKF's competition here
CMOPF vs DSNKY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, DSNKY has a market cap of 33.9B. Regarding current trading prices, CMOPF is priced at $109.00, while DSNKY trades at $18.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas DSNKY's P/E ratio is 19.71. In terms of profitability, CMOPF's ROE is -0.01%, compared to DSNKY's ROE of +0.19%. Regarding short-term risk, CMOPF is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check DSNKY's competition here
CMOPF vs DSKYF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, DSKYF has a market cap of 33.9B. Regarding current trading prices, CMOPF is priced at $109.00, while DSKYF trades at $18.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas DSKYF's P/E ratio is 19.70. In terms of profitability, CMOPF's ROE is -0.01%, compared to DSKYF's ROE of +0.19%. Regarding short-term risk, CMOPF is more volatile compared to DSKYF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check DSKYF's competition here
CMOPF vs ALPMF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, ALPMF has a market cap of 31.5B. Regarding current trading prices, CMOPF is priced at $109.00, while ALPMF trades at $17.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas ALPMF's P/E ratio is 40.93. In terms of profitability, CMOPF's ROE is -0.01%, compared to ALPMF's ROE of +0.20%. Regarding short-term risk, CMOPF is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check ALPMF's competition here
CMOPF vs ALPMY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, ALPMY has a market cap of 29.5B. Regarding current trading prices, CMOPF is priced at $109.00, while ALPMY trades at $16.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas ALPMY's P/E ratio is 38.33. In terms of profitability, CMOPF's ROE is -0.01%, compared to ALPMY's ROE of +0.20%. Regarding short-term risk, CMOPF is more volatile compared to ALPMY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check ALPMY's competition here
CMOPF vs ORINY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, ORINY has a market cap of 21.4B. Regarding current trading prices, CMOPF is priced at $109.00, while ORINY trades at $37.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas ORINY's P/E ratio is 18.44. In terms of profitability, CMOPF's ROE is -0.01%, compared to ORINY's ROE of +0.47%. Regarding short-term risk, CMOPF is more volatile compared to ORINY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check ORINY's competition here
CMOPF vs CSPCY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, CSPCY has a market cap of 14.7B. Regarding current trading prices, CMOPF is priced at $109.00, while CSPCY trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas CSPCY's P/E ratio is 25.50. In terms of profitability, CMOPF's ROE is -0.01%, compared to CSPCY's ROE of +0.05%. Regarding short-term risk, CMOPF is more volatile compared to CSPCY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check CSPCY's competition here
CMOPF vs GIKLY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, GIKLY has a market cap of 13.6B. Regarding current trading prices, CMOPF is priced at $109.00, while GIKLY trades at $5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas GIKLY's P/E ratio is 16.19. In terms of profitability, CMOPF's ROE is -0.01%, compared to GIKLY's ROE of +0.08%. Regarding short-term risk, CMOPF is more volatile compared to GIKLY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check GIKLY's competition here
CMOPF vs CHJTF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, CHJTF has a market cap of 11.7B. Regarding current trading prices, CMOPF is priced at $109.00, while CHJTF trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas CHJTF's P/E ratio is 20.40. In terms of profitability, CMOPF's ROE is -0.01%, compared to CHJTF's ROE of +0.05%. Regarding short-term risk, CMOPF is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check CHJTF's competition here
CMOPF vs ORINF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, ORINF has a market cap of 11.6B. Regarding current trading prices, CMOPF is priced at $109.00, while ORINF trades at $82.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas ORINF's P/E ratio is 20.23. In terms of profitability, CMOPF's ROE is -0.01%, compared to ORINF's ROE of +0.47%. Regarding short-term risk, CMOPF is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check ORINF's competition here
CMOPF vs RCDTF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, RCDTF has a market cap of 11.6B. Regarding current trading prices, CMOPF is priced at $109.00, while RCDTF trades at $56.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas RCDTF's P/E ratio is 23.24. In terms of profitability, CMOPF's ROE is -0.01%, compared to RCDTF's ROE of +0.21%. Regarding short-term risk, CMOPF is more volatile compared to RCDTF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check RCDTF's competition here
CMOPF vs GIFLF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, GIFLF has a market cap of 8.8B. Regarding current trading prices, CMOPF is priced at $109.00, while GIFLF trades at $12.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas GIFLF's P/E ratio is 20.48. In terms of profitability, CMOPF's ROE is -0.01%, compared to GIFLF's ROE of +0.08%. Regarding short-term risk, CMOPF is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check GIFLF's competition here
CMOPF vs GIFOF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, CMOPF is priced at $109.00, while GIFOF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas GIFOF's P/E ratio is 13.83. In terms of profitability, CMOPF's ROE is -0.01%, compared to GIFOF's ROE of +0.08%. Regarding short-term risk, CMOPF is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check GIFOF's competition here
CMOPF vs OPHLY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, OPHLY has a market cap of 7.5B. Regarding current trading prices, CMOPF is priced at $109.00, while OPHLY trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas OPHLY's P/E ratio is 23.00. In terms of profitability, CMOPF's ROE is -0.01%, compared to OPHLY's ROE of +0.08%. Regarding short-term risk, CMOPF is more volatile compared to OPHLY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check OPHLY's competition here
CMOPF vs OPHLF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, OPHLF has a market cap of 6.8B. Regarding current trading prices, CMOPF is priced at $109.00, while OPHLF trades at $14.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas OPHLF's P/E ratio is 20.49. In terms of profitability, CMOPF's ROE is -0.01%, compared to OPHLF's ROE of +0.08%. Regarding short-term risk, CMOPF is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check OPHLF's competition here
CMOPF vs KYKOF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, KYKOF has a market cap of 6.5B. Regarding current trading prices, CMOPF is priced at $109.00, while KYKOF trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas KYKOF's P/E ratio is 15.33. In terms of profitability, CMOPF's ROE is -0.01%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, CMOPF is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check KYKOF's competition here
CMOPF vs DPHAY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, CMOPF is priced at $109.00, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, CMOPF's ROE is -0.01%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, CMOPF is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check DPHAY's competition here
CMOPF vs SNPHY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, SNPHY has a market cap of 3.7B. Regarding current trading prices, CMOPF is priced at $109.00, while SNPHY trades at $11.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas SNPHY's P/E ratio is 19.81. In terms of profitability, CMOPF's ROE is -0.01%, compared to SNPHY's ROE of +0.11%. Regarding short-term risk, CMOPF is more volatile compared to SNPHY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check SNPHY's competition here
CMOPF vs SNPHF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, SNPHF has a market cap of 3.5B. Regarding current trading prices, CMOPF is priced at $109.00, while SNPHF trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas SNPHF's P/E ratio is 18.95. In terms of profitability, CMOPF's ROE is -0.01%, compared to SNPHF's ROE of +0.14%. Regarding short-term risk, CMOPF is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check SNPHF's competition here
CMOPF vs VRBCF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, VRBCF has a market cap of 3.2B. Regarding current trading prices, CMOPF is priced at $109.00, while VRBCF trades at $384.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas VRBCF's P/E ratio is 18.59. In terms of profitability, CMOPF's ROE is -0.01%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, CMOPF is more volatile compared to VRBCF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check VRBCF's competition here
CMOPF vs HAWPY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, HAWPY has a market cap of 3B. Regarding current trading prices, CMOPF is priced at $109.00, while HAWPY trades at $53.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas HAWPY's P/E ratio is 14.34. In terms of profitability, CMOPF's ROE is -0.01%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, CMOPF is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check HAWPY's competition here
CMOPF vs PTKFF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, PTKFF has a market cap of 2.7B. Regarding current trading prices, CMOPF is priced at $109.00, while PTKFF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas PTKFF's P/E ratio is N/A. In terms of profitability, CMOPF's ROE is -0.01%, compared to PTKFF's ROE of +0.16%. Regarding short-term risk, CMOPF is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check PTKFF's competition here
CMOPF vs HAWPF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, HAWPF has a market cap of 2.7B. Regarding current trading prices, CMOPF is priced at $109.00, while HAWPF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas HAWPF's P/E ratio is 12.90. In terms of profitability, CMOPF's ROE is -0.01%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, CMOPF is more volatile compared to HAWPF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check HAWPF's competition here
CMOPF vs LYPHF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, LYPHF has a market cap of 1.5B. Regarding current trading prices, CMOPF is priced at $109.00, while LYPHF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas LYPHF's P/E ratio is 18.88. In terms of profitability, CMOPF's ROE is -0.01%, compared to LYPHF's ROE of +0.03%. Regarding short-term risk, CMOPF is more volatile compared to LYPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check LYPHF's competition here
CMOPF vs TGRNF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, TGRNF has a market cap of 704.4M. Regarding current trading prices, CMOPF is priced at $109.00, while TGRNF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas TGRNF's P/E ratio is 11.00. In terms of profitability, CMOPF's ROE is -0.01%, compared to TGRNF's ROE of +0.05%. Regarding short-term risk, CMOPF is more volatile compared to TGRNF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check TGRNF's competition here
CMOPF vs JCRRF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, JCRRF has a market cap of 508.7M. Regarding current trading prices, CMOPF is priced at $109.00, while JCRRF trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas JCRRF's P/E ratio is -34.75. In terms of profitability, CMOPF's ROE is -0.01%, compared to JCRRF's ROE of -0.07%. Regarding short-term risk, CMOPF is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check JCRRF's competition here
CMOPF vs MAYNF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, MAYNF has a market cap of 134.1M. Regarding current trading prices, CMOPF is priced at $109.00, while MAYNF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas MAYNF's P/E ratio is -2.32. In terms of profitability, CMOPF's ROE is -0.01%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, CMOPF is more volatile compared to MAYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check MAYNF's competition here
CMOPF vs PTKFY Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, PTKFY has a market cap of 13.1M. Regarding current trading prices, CMOPF is priced at $109.00, while PTKFY trades at $11.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas PTKFY's P/E ratio is 12.15. In terms of profitability, CMOPF's ROE is -0.01%, compared to PTKFY's ROE of +0.15%. Regarding short-term risk, CMOPF is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check PTKFY's competition here
CMOPF vs PSYGF Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, PSYGF has a market cap of 2M. Regarding current trading prices, CMOPF is priced at $109.00, while PSYGF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas PSYGF's P/E ratio is -0.17. In terms of profitability, CMOPF's ROE is -0.01%, compared to PSYGF's ROE of -14.36%. Regarding short-term risk, CMOPF is more volatile compared to PSYGF. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check PSYGF's competition here
CMOPF vs CRXTQ Comparison April 2026
CMOPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMOPF stands at 1.8B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, CMOPF is priced at $109.00, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMOPF currently has a P/E ratio of -419.23, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, CMOPF's ROE is -0.01%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, CMOPF is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for CMOPF.Check CRXTQ's competition here